Sertaconazole-Nitrate-Loaded Leciplex for Treating Keratomycosis: Optimization Using D-Optimal Design and In Vitro, Ex Vivo, and In Vivo Studies
Creative Commons Attribution (CC-BY)
science
2022-10-18 00:00:00

Open AccessArticle by
 1,*, 1, 2 and 2 


1
Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza 12566, Egypt
 
2
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, El-Kasr El-Aini Street, Cairo 11562, Egypt


*
Author to whom correspondence should be addressed. 



Academic Editor: Giovanna Rassu

Pharmaceutics 2022, 14(10), 2215; https://doi.org/10.3390/pharmaceutics14102215 (registeringÂ DOI)


Received: 16 September 2022
/
Revised: 13 October 2022
/
Accepted: 14 October 2022
/
Published: 18 October 2022
 

This study aims to develop efficient topical therapy for keratomycosis using sertaconazolenitrate (STZN)-loaded leciplex (LP).
